If changing from a treatment regimen with an intermediate- or long-acting insulin (other than an insulin glargine product, 100 units/mL) to a regimen with BASAGLAR, a change in the dose of the basal insulin may be required and the amount and timing of shorter-acting insulins and doses ...
甘精和地特胰岛素对3T3-L1脂肪细胞瘦素mRNA表达的影响摘要目的:探讨甘精胰岛素和地特胰岛素对体外3T3-L1脂肪细胞瘦素mRNA表达的影响。方法:1.体外培养3T3-L1前脂肪细胞,并分化为成熟的脂肪细胞。2.诱导液刺激分化后的3T3-L1脂肪细胞。根据诱导液所含胰岛素种类不同随机分为4大组:人胰岛素(纯品)、甘精胰岛素(纯品)、...
Insulin glargine is a long-acting insulin used to treat type 1 and type 2 diabetes in certain patients to improve and maintain blood glucose levels. Insulin glargine is a man-made form of human insulin that is used once daily to provide a base level of insulin that keeps working for 24 ...
Since insulin is frequently used in such patients, the effect of glulisine (short acting) and glargine (long acting) were tested in Zucker fatty rat carotid artery subjected to balloon catheter injury. Insulin resistant Zucker fatty rats were sc injected 0.45 mg/kg of glargine (once) or glu...
serious and life-threatening.Severe hypoglycemia may cause harm to your heart or brain. Symptoms of serious low blood sugar may include shaking, sweating, fast heartbeat, and blurred vision. The long-acting effect of Toujeo may delay recovery from low blood sugar compared to shorter-acting ...
BASAGLAR® is a long-acting basal insulin used to control high blood sugar in adults and children with type 1 diabetes and adults with type 2 diabetes.
Insulin glargine (300 units/mL; Toujeo): Treatment of type 1 or type 2 diabetes mellitus in adults who require long-acting insulin for control of hyperglycemia.Insulin glargine not the insulin of choice for treatment of diabetic ketoacidosis; short-acting IV insulins are preferred....
Hypersensitivity to either of the active drugs or any excipients Effects of drug abuse None Short-Term Effects See “What Are Side Effects Associated with Using Insulin Glargine-Lixisenatide?” Long-Term Effects See “What Are Side Effects Associated with Using Insulin Glargine-Lixisenatide?” ...
Starting Dose In Patients With Either Type 1 Or Type 2 Diabetes Already On Insulin Therapy To minimize the risk of hypoglycemia when changing patients from a once-daily long-acting or intermediate-acting insulin product to TOUJEO, the starting dose of TOUJEO can be the same as the once-daily...
Lantus® is a long acting insulin used in adults with type 2 diabetes and adults and children (6 years of age and older) with type 1 diabetes to manage their A1C and control their blood sugar. See Important Safety Information.